Free Trial

Singular Genomics Systems (OMIC) Stock Forecast & Price Target

-0.07 (-0.86%)
(As of 07/22/2024 ET)

Singular Genomics Systems - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 2 Wall Street analysts who have issued ratings for Singular Genomics Systems in the last 12 months, the stock has a consensus rating of "Hold." Out of the 2 analysts, 2 have given a hold rating for OMIC.

Consensus Price Target

32.72% Upside
High Forecast$15.00
Average Forecast$10.75
Low Forecast$6.50

According to the 2 analysts' twelve-month price targets for Singular Genomics Systems, the average price target is $10.75. The highest price target for OMIC is $15.00, while the lowest price target for OMIC is $6.50. The average price target represents a forecasted upside of 32.72% from the current price of $8.10.

TypeCurrent Forecast
7/24/23 to 7/23/24
1 Month Ago
6/24/23 to 6/23/24
3 Months Ago
4/25/23 to 4/24/24
1 Year Ago
7/24/22 to 7/24/23
Consensus Rating
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$10.75$18.75$20.25$105.00
Forecasted Upside32.72% Upside34.42% Upside48.14% Upside-1.96% Downside
Get Singular Genomics Systems Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OMIC and its competitors with MarketBeat's FREE daily newsletter.

OMIC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OMIC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Singular Genomics Systems Stock vs. The Competition

TypeSingular Genomics SystemsMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside32.72% Upside3,075.36% Upside9.59% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/9/2024The Goldman Sachs Group
2 of 5 stars
 Lower TargetNeutral ➝ Neutral$22.50 ➝ $6.50-13.91%
3/20/2024UBS Group
4 of 5 stars
 Boost TargetNeutral ➝ Neutral$12.00 ➝ $15.00-0.06%
8/10/2022Bank of America
4 of 5 stars
 DowngradeBuy ➝ Underperform$90.00-32.58%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:53 PM ET.

OMIC Forecast - Frequently Asked Questions

What is Singular Genomics Systems' forecast for 2024?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Singular Genomics Systems is $10.75, with a high forecast of $15.00 and a low forecast of $6.50.

Should I buy or sell Singular Genomics Systems stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares.

Does Singular Genomics Systems's stock price have much downside?

According to analysts, Singular Genomics Systems's stock has a predicted downside of -4.69% based on their 12-month stock forecasts.

What analysts cover Singular Genomics Systems?

Singular Genomics Systems has been rated by research analysts at The Goldman Sachs Group in the past 90 days.

Do Wall Street analysts like Singular Genomics Systems more than its competitors?

Analysts like Singular Genomics Systems less than other "medical" companies. The consensus rating for Singular Genomics Systems is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OMIC compares to other companies.

This page (NASDAQ:OMIC) was last updated on 7/23/2024 by Staff

From Our Partners